R-216073

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameR-216073
Drug Alias NameR-216073
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsDyspepsia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsDyspepsia

Other Information

ATC CodeN/A
Related LinksN/A